mProX™ Human SSTR1 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- GPCR Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Quintion
Verified Customer
Donahue
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Knock-down of SSTR1 promoted cell-cycle progression.
Using flow cytometry, the cell-cycle percentage in AGS and BGC823 cells transfected with sh-control and sh-SSTR1, respectively, was examined. effects of SSTR1 knockdown on cell-cycle regulators p15, p21, and p27 protein expression by western blot.
Ref: Zhao, Junhong, et al. "Somatostatin receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer." British journal of cancer 108.12 (2013): 2557-2564.
Pubmed: 23722468
DOI: 10.1038/bjc.2013.263
Research Highlights
A subtype of somatostatin receptors called somatostatin receptor 1 (SSTR1) is engaged in a number of signaling processes in diverse regions of the human body. The study's findings may help in the development of stronger and more inventive SSTR1 antagonists and agonists.
Nagarajan, Santhosh Kumar, et al. "Molecular-level understanding of the somatostatin receptor 1 (SSTR1)-ligand binding: a structural biology study based on computational methods." ACS omega 5.33 (2020): 21145-21161.
Pubmed:
32875251
DOI:
10.1021/acsomega.0c02847
Studies hypothesize that SST signaling regulates the rate of NEC maturation as SCs progress along the NEC lineage, which contributes to SC quiescence and inhibition of proliferation because SST and SSTR1 are not expressed in ALDH+ cells.
Modarai, Shirin R., et al. "Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells." BMC cancer 16.1 (2016): 1-12.
Pubmed:
27927191
DOI:
10.1186/s12885-016-2969-7